HomeNRX • CVE
add
Nurexone Biologic Inc
Previous close
$0.66
Day range
$0.62 - $0.66
Year range
$0.26 - $1.19
Market cap
46.60M CAD
Avg Volume
44.79K
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 812.00K | 34.66% |
Net income | -1.32M | -27.40% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -1.31M | -24.00% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.38M | 171.02% |
Total assets | 3.29M | 171.84% |
Total liabilities | 717.00K | 37.62% |
Total equity | 2.58M | — |
Shares outstanding | 67.49M | — |
Price to book | 16.50 | — |
Return on assets | -88.78% | — |
Return on capital | -105.52% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | -1.32M | -27.40% |
Cash from operations | -870.00K | -25.00% |
Cash from investing | -71.00K | -3,450.00% |
Cash from financing | 44.00K | 4,500.00% |
Net change in cash | -870.00K | -22.88% |
Free cash flow | -359.62K | -5.38% |
About
Founded
2011
Website
Employees
12
